COVID-19 Associated Myocarditis: Prevalence, Pathophysiology, Diagnosis, and Management
Ji Yan1,2, Jiang Hong1
1From the Department of Internal and Emergency Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause COVID-19, leading to myocarditis. This study explores the cardiovascular complications of COVID-19, including diagnosis and treatment.
Area of Science:
- Cardiology
- Virology
- Immunology
Background:
- COVID-19, caused by SARS-CoV-2, significantly impacts global public health.
- While primarily a respiratory illness, COVID-19 also affects other organs, notably the cardiovascular system.
- Myocarditis is a serious complication of COVID-19 with potentially adverse outcomes.
Purpose of the Study:
- To investigate the mechanisms behind COVID-19-induced myocarditis.
- To review the clinical manifestations and diagnostic approaches for COVID-19 myocarditis.
- To compare COVID-19 myocarditis with other forms of viral myocarditis.
Main Methods:
- Review of existing literature on COVID-19 and cardiovascular complications.
- Analysis of clinical data including cardiac biomarkers, ECG, echocardiography, and cardiac MRI.
- Discussion of endomyocardial biopsy as a diagnostic tool.
Main Results:
- Elevated cardiac biomarkers, ECG abnormalities, and impaired cardiac function are key indicators.
- Angiotensin-Converting Enzyme2 (ACE2) plays a role in SARS-CoV-2 infection.
- Immune overresponse and potentially direct viral injury contribute to myocardial damage.
Conclusions:
- COVID-19 myocarditis is a significant concern requiring thorough diagnostic evaluation.
- Understanding the pathogenesis is crucial for effective treatment strategies.
- Further research is needed to fully elucidate the role of direct viral injury.
Abstract:
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a pandemic and affected public health greatly. While COVID-19 primarily damages the lungs, leading to cough, sore throat, pneumonia, or acute respiratory distress syndrome, it also infects other organs and tissues, including the cardiovascular system. In particular, myocarditis is a well-recognized severe complication of COVID-19 infection and could result in adverse outcomes. Angiotensin-Converting Enzyme2 is thought to play a pivotal role in SARS-CoV-2 infection, and immune overresponse causes overwhelming damage to the host's myocardium. Direct viral infection and injury do take a part as well, but more evidence is needed to strengthen this proposal. The clinical abnormalities include elevated cardiac biomarkers and electrocardiogram changes and impaired cardiac function that might be presented in echocardiography and cardiovascular magnetic resonance imaging. If necessary, the endomyocardial biopsy would give more forceful information to diagnosis and aid in treatment. Comparisons between COVID-19 myocarditis and other viral myocarditis are also discussed briefly.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis IV: Nursing Management
Cardiomyopathy I: Introduction and Classification
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations


